Register now to participate.
Eagerly anticipated and now underway – a landmark UK medical research study on MicroPulse® Transscleral Laser Therapy (MPTLT) for the treatment of glaucoma using Iridex’ Cyclo G6® Laser and the MicroPulse P3® Delivery Device.
A NICE-compliant registry of MPTLT treatments has been developed by Professor Philip Bloom and Dr Eduardo Normando, working at the Western Eye Hospital (Imperial College Healthcare NHS Trust) in collaboration with Iridex Corporation (Mountain View, California). This study has now been approved for rolling out nationally to other eye units in the UK.
Calling all G6 Cyclodiode users to register to join this innovative research initiative - compliant with NICE IPG692 guidance.
Professor Philip Bloom.
"This study represents a significant advance in clinical research and technology innovation. Imperial College Healthcare NHS Trust pursues research in accordance with the strictest ethical and regulatory standards, and this collaboration with Iridex demonstrates a shared vision for advancing clinical practice with MicroPulse® TLT. The study promises meaningful new insights into glaucoma laser therapy, potentially reforming treatment approaches and substantially enhancing patient care." Professor Philip Bloom - Imperial College.
To register for more information, please contact imperial.ukmptltstudy@nhs.net.
